QHSLab, Inc. Files 8-K Report

Ticker: USAQ · Form: 8-K · Filed: Sep 2, 2025 · CIK: 856984

Sentiment: neutral

Topics: 8-K, disclosure, financials

TL;DR

QHSLab, Inc. filed an 8-K on 9/2/25 covering Reg FD and financials.

AI Summary

On September 2, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and Exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and operates in the Surgical & Medical Instruments & Apparatus industry.

Why It Matters

This 8-K filing provides important updates and disclosures for QHSLab, Inc., which could impact investor understanding of the company's current status and regulatory compliance.

Risk Assessment

Risk Level: low — This filing is a routine 8-K report and does not appear to contain any immediately alarming or significant negative news.

Key Players & Entities

FAQ

What specific items are included in the Financial Statements and Exhibits section of the 8-K filing?

The filing indicates that Financial Statements and Exhibits are included, but the specific details of these exhibits are not provided in the provided text.

What is the primary purpose of this 8-K filing for QHSLab, Inc.?

The primary purposes are Regulation FD Disclosure and the inclusion of Financial Statements and Exhibits, as indicated by the 'ITEM INFORMATION' section.

When was QHSLab, Inc. previously known by other names?

The company was formerly known as USA EQUITY CORP. (name change 20151116), USA EQUITIES CORP. (name change 20151119), and AMERICAN BIOGENETIC SCIENCES INC (name change 19940426).

In which state is QHSLab, Inc. incorporated?

QHSLab, Inc. is incorporated in Nevada.

What is the business and mailing address for QHSLab, Inc.?

The business and mailing address for QHSLab, Inc. is 901 Northpoint Parkway Suite 302, West Palm Beach, FL 33407.

Filing Stats: 749 words · 3 min read · ~2 pages · Grade level 10.8 · Accepted 2025-09-02 13:16:07

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 2, 2025 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing